ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced that it will present new data from the ARCADIA and OLYMPIA clinical trial programs investigating nemolizumab in atopic dermatitis and ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has completed enrollment in SHASTA-3, SHASTA-4, and MUIR-3, the company’s global Phase 3 ...

Three Business, the enterprise arm of Three UK, has embarked on a large-scale trial eSIM, offering over 50,000 businesses in Birmingham and Bristol a way to test its network before making a commitment ...